J Am Board Fam Med 2017 Nov-Dec;30(6):701-714
From Tabula Rasa HealthCare, Moorestown, NJ (EJS, JT, OVK, CHK, KTB); Elmwood Family Physicians, Evesham Township, NJ (JP, PP, HS); Personalized Medicine & Targeted Therapeutics, University of the Sciences, Philadelphia, PA (AMI).
Purpose: The purpose of this study was to implement a clinical pharmacist-led medication therapy management (MTM) service within a primary-care setting that is enhanced by 1) a clinical decision support system (CDSS) that includes a unique combination of medication risk mitigation factors, which aids the pharmacist in interpreting the medication profile, and 2) pharmacogenomics (PGx) testing.
Methods: This was a service implementation study, whereby Medicare beneficiaries were eligible if they were patients of Elmwood Family Physicians, a private family, primary care practice with 2 locations in New Jersey, and were on at least 7 medications. Patients had a medication reconciliation completed by a pharmacist and performed a PGx buccal swab. Read More